Apimeds Pharmaceuticals US (APUS) Current Assets (2023 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Current Assets came in at $14.0 million in Q4 2025, up 106998.56% YoY from N/an in Q4 2024, and up 53.9% on a QoQ basis from $9.1 million in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Current Assets (2023 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 3 years of Current Assets data on file, last reported at $14.0 million in Q4 2025.
- Quarterly Current Assets rose 106998.56% year-over-year to $14.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.0 million (up 106998.56% YoY) and the FY2025 annual result came in at $14.0 million, up 106998.56% from the prior year.
- Current Assets improved to $14.0 million in Q4 2025, from $9.1 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $14.0 million in Q4 2025 to a low of $13057.0 in Q4 2024.
- A 3-year average of $5.7 million and a median of $4.8 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets sank 96.91% — and 2025, when it soared 106998.56%.
- Tracing APUS's Current Assets over 3 years: stood at $422076.0 in 2023, then slumped by 96.91% to $13057.0 in 2024, then soared by 106998.56% to $14.0 million in 2025.
- The last three Current Assets figures came in at $14.0 million (Q4 2025), $9.1 million (Q3 2025), and $10.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 3.22 Bn |
| 10 | Apimeds Pharmaceuticals US | 7.12 Mn | 7.12 Mn | - | 10.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.98 Mn |
| Sep 30, 2025 | 9.09 Mn |
| Jun 30, 2025 | 10.35 Mn |
| Mar 31, 2025 | 259,904.00 |
| Dec 31, 2024 | 13,057.00 |
| Dec 31, 2023 | 422,076.00 |